Search

everythinglearnresearchcommunity

for

Search:↓

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Mutations in certain receptors can cause diseases and offer new treatment options.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Vitamin D receptor helps control hair growth genes in skin cells.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.